Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 9 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/05/2021 72 13
Rapamycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/11/2020 5 0
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/06/2020 7 0
Almitrine Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/21/2020 3 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/18/2020 10 0
Nebivolol Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/16/2020 2 0
Calpain inhibitor II Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/05/2020 2 0
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Sep/05/2020 5 0
Calpain inhibitor XII Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/05/2020 2 0